Skip to main content

Advertisement

SpringerLink
Log in

Is valsartan renoprotective in patients with IgA nephropathy?

  • Practice Point
  • Published:

From Nature Clinical Practice Nephrology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Brenner BM et al. (2001) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345: 861–869

    Article  CAS  Google Scholar 

  2. Lewis EJ et al. (2001) Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345: 851–860

    Article  CAS  Google Scholar 

  3. Lewis EJ et al. (1993) The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 329: 1456–1462

    Article  CAS  Google Scholar 

  4. Praga M et al. (2003) Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial. J Am Soc Nephrol 14: 1578–1583

    Article  CAS  Google Scholar 

  5. Bartosik LP et al. (2001) Predicting progression in IgA nephropathy. Am J Kidney Dis 38: 728–735

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Chloë Harman, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Professor of Medicine at the University of Toronto, and Senior Research Scientist, Toronto General Research Institute, Toronto, ON, Canada

    Daniel C Cattran

Authors
  1. Daniel C Cattran
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniel C Cattran.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cattran, D. Is valsartan renoprotective in patients with IgA nephropathy?. Nat Rev Nephrol 2, 610–611 (2006). https://doi.org/10.1038/ncpneph0303

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0303

  • Springer Nature Limited

Search

Navigation